MTBVac: Bharat Biotech To Launch New TB Vaccine

Bharat Biotech has revealed plans to bring MTBVac, a new vaccine aimed at preventing tuberculosis in India. The company has successfully completed two phases of clinical trials and is now preparing for the 3rd phase, expected to commence in early 2026. MTBVac represents a key step forward in the fight against TB in the country.